NO832039L - Fremgangsmaate for fremstilling av lagringsstabile tabletter inneholdende hydrolysefoelsomme virkestoffer - Google Patents

Fremgangsmaate for fremstilling av lagringsstabile tabletter inneholdende hydrolysefoelsomme virkestoffer

Info

Publication number
NO832039L
NO832039L NO832039A NO832039A NO832039L NO 832039 L NO832039 L NO 832039L NO 832039 A NO832039 A NO 832039A NO 832039 A NO832039 A NO 832039A NO 832039 L NO832039 L NO 832039L
Authority
NO
Norway
Prior art keywords
tablet
active substance
layer
preparation
hydroolyse
Prior art date
Application number
NO832039A
Other languages
English (en)
Norwegian (no)
Inventor
Michael Schmidt
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of NO832039L publication Critical patent/NO832039L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO832039A 1982-06-07 1983-06-06 Fremgangsmaate for fremstilling av lagringsstabile tabletter inneholdende hydrolysefoelsomme virkestoffer NO832039L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823221425 DE3221425A1 (de) 1982-06-07 1982-06-07 Hydrolyseempfindlichen wirkstoff enthaltende, lagerstabile tablette

Publications (1)

Publication Number Publication Date
NO832039L true NO832039L (no) 1983-12-08

Family

ID=6165523

Family Applications (1)

Application Number Title Priority Date Filing Date
NO832039A NO832039L (no) 1982-06-07 1983-06-06 Fremgangsmaate for fremstilling av lagringsstabile tabletter inneholdende hydrolysefoelsomme virkestoffer

Country Status (14)

Country Link
US (1) US4786507A (h)
EP (1) EP0096286A3 (h)
JP (1) JPS591413A (h)
AU (1) AU556373B2 (h)
DE (1) DE3221425A1 (h)
DK (1) DK257383A (h)
FI (1) FI831952A7 (h)
GB (1) GB2123289B (h)
GR (1) GR78281B (h)
IE (1) IE55140B1 (h)
IL (1) IL68891A0 (h)
NO (1) NO832039L (h)
NZ (1) NZ204478A (h)
ZA (1) ZA834074B (h)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61140520A (ja) * 1984-12-12 1986-06-27 Lion Corp アセチルサリチル酸製剤
US4898733A (en) * 1985-11-04 1990-02-06 International Minerals & Chemical Corp. Layered, compression molded device for the sustained release of a beneficial agent
IT1201136B (it) * 1987-01-13 1989-01-27 Resa Farma Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive
HU211648A9 (en) * 1990-03-28 1995-12-28 Chinoin Gyogyszer Es Vegyeszet Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same
HU210921B (en) * 1990-03-28 1995-09-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine formed with cyclodextrines and pharmaceutical compositions containing them
US5213807A (en) * 1990-05-03 1993-05-25 Chemburkar Pramod B Pharmaceutical composition containing ibuprofen and a prostaglandin
US6896696B2 (en) * 1998-11-20 2005-05-24 Scimed Life Systems, Inc. Flexible and expandable stent
US6981986B1 (en) 1995-03-01 2006-01-03 Boston Scientific Scimed, Inc. Longitudinally flexible expandable stent
WO1996026689A1 (en) 1995-03-01 1996-09-06 Scimed Life Systems, Inc. Improved longitudinally flexible expandable stent
US7204848B1 (en) 1995-03-01 2007-04-17 Boston Scientific Scimed, Inc. Longitudinally flexible expandable stent
US6818014B2 (en) * 1995-03-01 2004-11-16 Scimed Life Systems, Inc. Longitudinally flexible expandable stent
DE19524753A1 (de) * 1995-07-07 1997-01-23 Lohmann Therapie Syst Lts Schichttablette zur kontrollierten Freisetzung von Wirkstoffen
US8070792B2 (en) * 2000-09-22 2011-12-06 Boston Scientific Scimed, Inc. Stent
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
CA2566310C (en) * 2004-05-21 2014-05-13 Lawrence Solomon Scored pharmaceutical tablets comprising a plurality of segments
ES2607988T3 (es) 2005-05-31 2017-04-05 Iams Europe B.V. Bifidobacterias probióticas felinas
WO2006130187A1 (en) 2005-05-31 2006-12-07 The Iams Company Feline probiotic lactobacilli
BRPI0808391A2 (pt) * 2007-02-01 2014-07-08 Lams Company Método para diminuir a inflamação e o estresse em um mamífero, mediante o uso de antimetabólitos de glicose, abacate ou extratos de abacate.
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
WO2012119037A1 (en) 2011-03-03 2012-09-07 Boston Scientific Scimed, Inc. Stent with reduced profile
EP2680797B1 (en) 2011-03-03 2016-10-26 Boston Scientific Scimed, Inc. Low strain high strength stent
JP7502308B2 (ja) * 2019-01-18 2024-06-18 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 固体投与形態を製造する方法および固体投与形態

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH43905A (de) * 1908-10-13 1909-06-16 Theo Dill Zweiteilige Tabelle für gepreßte, im Wasser verteilbare Produkte
DE657259C (de) * 1936-05-20 1938-03-01 Ludwig Heumann & Co Chem Pharm Pressling fuer pharmazeutische Zwecke
NL6601426A (h) * 1965-02-12 1966-08-15
GB1160085A (en) * 1965-10-23 1969-07-30 Squibb & Sons Inc Tablets
US3833580A (en) * 1966-08-09 1974-09-03 Boehringer Sohn Ingelheim 3-morpholino-n6-cyclohexylcarbonyl sydnonimine
DE1813752A1 (de) * 1968-12-10 1970-06-25 Boehringer Sohn Ingelheim Neue substituierte 3-Amino-sydnonimine und Verfahren zu ihrer Herstellung
GB1309597A (en) * 1969-05-09 1973-03-14 Colorcon Stabilised shellac sealing coating for tablets
US3692562A (en) * 1969-12-02 1972-09-19 Ryuichi Kawata Coated tablets having plastic particles dispersed in the coating
FR2100858B1 (h) * 1970-07-03 1975-06-06 Daiichi Seiyaku Co
JPS4837815B1 (h) * 1970-09-25 1973-11-14 Yamanouchi Pharma Co Ltd
GB1318757A (en) * 1970-11-16 1973-05-31 Yamanouchi Pharma Co Ltd Method of sugar coating tablets
GB1346610A (h) * 1971-07-02 1974-02-13
GB1456365A (en) * 1972-10-06 1976-11-24 Gist Brocades Nv Controlled release composition
FR2211213B1 (h) * 1972-12-26 1976-04-23 Montagne Noire Prod Chim
JPS5315542B2 (h) * 1973-03-01 1978-05-25
JPS5154918A (en) * 1974-10-08 1976-05-14 Nippon Kayaku Kk Jozaino seizoho
US4139589A (en) * 1975-02-26 1979-02-13 Monique Beringer Process for the manufacture of a multi-zone tablet and tablet manufactured by this process
DE2512247A1 (de) * 1975-03-20 1976-10-14 Thomae Gmbh Dr K Gegen feuchtigkeit stabilisierte presslinge mit feuchtigkeitsempfindlichen inhaltsstoffen
JPS51123814A (en) * 1975-04-22 1976-10-28 Shin Etsu Chem Co Ltd A process for preparing gradually releasable solid medicines
GB1509866A (en) * 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
CH649216A5 (de) * 1979-08-16 1985-05-15 Sandoz Ag Verfahren zur auftragung eines magensaftresistenten filmes auf einen heilmittelkern und feste einheitsdosierungsform mit magensaftresistentem film.

Also Published As

Publication number Publication date
DE3221425A1 (de) 1983-12-08
FI831952L (fi) 1983-12-08
EP0096286A3 (de) 1984-10-10
FI831952A7 (fi) 1983-12-08
US4786507A (en) 1988-11-22
DK257383A (da) 1983-12-08
GB8315489D0 (en) 1983-07-13
IE55140B1 (en) 1990-06-06
IE831313L (en) 1983-12-07
NZ204478A (en) 1985-07-12
GB2123289B (en) 1986-08-28
AU556373B2 (en) 1986-10-30
GR78281B (h) 1984-09-26
AU1544583A (en) 1983-12-15
DK257383D0 (da) 1983-06-06
FI831952A0 (fi) 1983-06-01
IL68891A0 (en) 1983-10-31
EP0096286A2 (de) 1983-12-21
ZA834074B (en) 1985-02-27
JPS591413A (ja) 1984-01-06
GB2123289A (en) 1984-02-01

Similar Documents

Publication Publication Date Title
NO832039L (no) Fremgangsmaate for fremstilling av lagringsstabile tabletter inneholdende hydrolysefoelsomme virkestoffer
DE60222803T2 (de) Orale kapselformulierung mit verbesserter physikalischer stabilität
US5635209A (en) Stabilized composition of levothyroxine sodium medication and method for its production
CA2390933C (en) Oral solid preparation comprising 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide
FI84781B (fi) Foerfarande foer produktion av en stabil nikorandilprodukt.
US3256153A (en) Method of stabilizing wax-fat coating materials and product thereof
US3922338A (en) Tablets containing in their mass controlled-release micro-capsules and process for manufacture of said tablets
US5958979A (en) Stabilized medicaments containing thyroid hormones
NO155476B (no) Fremgangsmaate til fremstilling av en kapsel inneholdende acetylsalicylsyre.
US20100158998A1 (en) Formulations comprising vitamin d or derivatives thereof
NO173590B (no) Fremgangsmaate for fremstilling av et stabilt nikorandilholdig farmasoeytisk preparat
EA007619B1 (ru) Пленочное покрытие для таблеток и каплет
AU2001294735B2 (en) Stabilization of solid drug formulations
DE202009019152U1 (de) Stabile verpackte Dosierungsform eines Kombinationspräparats umfassend eine pharmazeutische Zusammensetzung enthaltend Amlodipin-Besylat und Bisoprolol- Fumarat
US4601895A (en) Delayed-action acetylsalicylic acid formulations for oral administration
KR20030024849A (ko) 소수성 약물의 개선된 고형 약제학적 투여 제제
CA2641575C (en) Stabilization of solid thyroid drug formulations
CN1321642C (zh) 泮托拉唑钠肠溶微丸
AU2001291244A1 (en) Stabilization of solid thyroid drug formulations
MXPA05006203A (es) Formulaciones estables de topiramato.
CA2259727A1 (en) A two-layer pharmaceutical tablet comprising an nsaid and misoprostol
CN102210693A (zh) 一种阿司匹林和双嘧达莫多层片的制备方法
DE2512247A1 (de) Gegen feuchtigkeit stabilisierte presslinge mit feuchtigkeitsempfindlichen inhaltsstoffen
CN211461322U (zh) 一种阿托伐他汀钙和苯磺酸氨氯地平的复方三层片
EP0770386B1 (en) Lanperisone formulation